首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Infectious Diseases And Therapy

Infectious Diseases And Therapy杂志,由Springer Healthcare出版,于2012年创刊,6 issues per year,出版语言English,ISSN:2193-8229,E-ISSN:2193-6382。

投稿咨询
Infectious Diseases And Therapy
Infectious Diseases And Therapy
Infectious Diseases And Therapy
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
5.6
CiteScore
9.3
期刊收录
SCI、SCIE

Infectious Diseases And Therapy(中文译名:《传染病与治疗》),ISSN:2193-8229,EISSN:2193-6382,是Springer Healthcare出版的国际性学术期刊,创刊于2012年,以6 issues per year形式稳定发行,2026年总发文量约173篇。该刊采用OA开放访问,学科归属为Medicine - Microbiology (medical)。该刊是医学、传染病学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达5.6,2025年期刊CiteScore为9.3,2025年期刊自引率约5.4%,在中科院期刊分区体系中位列医学大类2区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Infectious Diseases And Therapy长期聚焦医学、传染病学及相关产业的技术应用前沿,平均审稿周期6 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、传染病学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAEngland、Italy、GERMANY (FED REP GER)、Belgium、Canada、CHINA MAINLAND等为核心发文国家与地区;WAYNE STATE UNIVERSITYPFIZER、GLAXOSMITHKLINE、DETROIT MEDICAL CENTER、NATIONAL & KAPODISTRIAN UNIVERSITY OF ATHENS、HENRY FORD HOSPITAL、UNIVERSITY OF CALIFORNIA SYSTEM等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
INFECTIOUS DISEASES 传染病学
2区
是 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
INFECTIOUS DISEASES 传染病学
2区
否 否

期刊分区表(2022年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
INFECTIOUS DISEASES 传染病学
3区
否 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:INFECTIOUS DISEASES SCIE Q1 16 / 141

89

学科:INFECTIOUS DISEASES SCIE Q1 15 / 141

89.72

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:INFECTIOUS DISEASES SCIE Q1 20 / 132

85.2

学科:INFECTIOUS DISEASES SCIE Q1 32 / 132

76.14


中国学者近期发文

1
Antibiotic Pharmacokinetics and Prostate Penetration in Bacterial Prostatitis: A Systematic Revie

Author:Ge, Rui; Nian, Xinwen; Liu, Benjuan; Yang, Yunyun; Wang, Zhuo

Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. 15, Issue 5, pp. 1203-1248. DOI: 10.1007/s40121-026-01341-4

2
Post-marketing Safety Surveillance of 23-Valent Pneumococcal Polysaccharide Vaccine Administered Alone and Concomitantly with Influenza Vaccine in Individuals Aged 2 Years and Older in Chin

Author:Shi, Yun-feng; Ju, Lin-hang; Wang, Kang-ning; Pan, Yu; Zou, Yu-ying; Lu, Xi; Tuo, Ling; Zou, Wen-tao; Wei, Ming-wei; Zhao, Yan-wei; Pan, Hong-xing

Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-026-01309-4

3
Reimagining Phage Therapy for MDR Pathogens: From Biobanks to Health System Integration-A Revie

Author:Ayele, Abay A.; Liu, Wenfeng; Xiao, Minfeng; Kalayu, Alem A.; Abegaz, Woldaregay E.; Negash, Abel A

Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-026-01320-9

4
The Impact and Effectiveness of a Two-Dose Varicella Immunization Program Among School Children: Evidence from Quasi-experimental Analyse

Author:Gu, Huiqiao; Xie, Xu; Lv, Qiuying; Cui, Yuantian; Lu, Ziyan; Akhmetova, Zaure; Shulgau, Zarina; Huang, Fang; Jiang, Yawen

Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-026-01331-6

5
Rising Burden of Herpes Zoster among General Adults and Increased-Risk Groups in Eastern China, 2015-2021: A Population-Based Cohort Stud

Author:Li, Zhenwei; Gu, Shenjia; Li, Jiajun; Zhang, Guomin; Wu, Zheng; Lin, Hongbo; Chen, Kan; Xu, Zhexin; Fu, Chuanxi

Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-026-01308-5

6
Early Antibiotic Therapy in Sepsis Without Shock: A Multimethod Study of Heterogeneous Treatment Effects in ICU Patient

Author:Zhang, Peng; Zuo, Tongkun; Zhu, Xingxing; Wei, Jilou; Wang, Min; Zhang, Xiangcheng; Huang, Ying

Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-026-01316-5

7
How Status Quo Bias Shapes Willingness, Uptake, and Adherence to PrEP Among Chinese MSM: A Behavioral Economics Perspectiv

Author:Zhao, Min; Zhao, Xiang; Zhang, Ye; Yin, Zhuoheng; Ji, Fanpu; Ong, Jason J.; Tang, Weiming; Zhang, Lei

Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-025-01296-y

8
Efficacy, Safety, and Cost-Effectiveness Analysis of Ceftazidime-Avibactam versus Polymyxin B in the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: A Target Trial Emulatio

Author:Hu, Na; Xiao, Fengjiao; Chen, Yechao; Gu, Qiaoling; Liang, Pei; Xu, Yin; Liu, Jinchun; Liu, Yunxing; Li, Yi-chen; Xu, Yinqiu; Liu, Mengyin; Chen, Dayu; Zhang, Haixia

Journal: INFECTIOUS DISEASES AND THERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s40121-025-01164-9

9
Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study

Author:Huang, Chung-Feng; Heo, Jeong; Chien, Rong-Nan; Baek, Yang-Hyun; Kao, Jia-Horng; Kim, Ju-Hyun; Chang, Ting-Tsung; Byun, Kwan-Soo; Chen, Jyh-Jou; Jeong, Sook-Hyang; Hu, Tsung-Hui; Kim, Young-Seok; Peng, Cheng-Yuan; Tak, Won-Young; Wang, Horng-Yuan; Yoon, Seung-Kew; Sheen, I. -Shyan; Hsu, Yu-Chun; Yim, Hyung-Joon; Tsai, Pei-Chien; Yeh, Ming-Lun; Ahn, Sang-Hoon; Dai, Chia-Yen; Paik, Seung-Woon; Huang, Jee-Fu; Kim, Yoon-Jun; Chuang, Wan-Long; Lim, Young-Suk; Yu, Ming-Lung

Journal: INFECTIOUS DISEASES AND THERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s40121-025-01145-y

10
Epidemiology and Antimicrobial Resistance of Stenotrophomonas maltophilia in China, 2014-202

Author:Wang, Hanli; Li, Shirong; Ji, Haoyu; Hu, Yixin; Zhou, Susheng; Chen, Xingwu; Lu, Zhiwei; You, Qinghai; Cheng, Yusheng; Zha, Lei

Journal: INFECTIOUS DISEASES AND THERAPY. 2025; Vol. 14, Issue 1, pp. 261-274. DOI: 10.1007/s40121-024-01099-7


在线咨询

Infectious Diseases And Therapy

国际简称:INFECT DIS THER参考译名:传染病与治疗

年发文量:173 CiteScore:9.3 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:81.50%

杂志社联系方式:236 GRAYS INN RD, 6TH FLOOR, LONDON, ENGLAND, WC1X 8HL

Infectious Diseases And Therapy